| How can we reduce complications associated with thrombolysis for prosthetic valve thrombosis? (To the Editor,) | SABAHATTİN GÜNDÜZ,MAHMUT YESİN,MACİT KALÇIK,Mustafa Ozan GÜRSOY,Mehmet ÖZKAN | 0–0 |
| Citius, Altius, Fortius | Zeki ÖNGEN | 601–601 |
| Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies? | BÜLENT GÖRENEK,Gulmira KUDAİBERDİEVA,Bektash MORRAD | 602–604 |
| Unmasking of atrial repolarization waves using a simple modified limb lead system | Sivaraman JAYARAMAN,Uma GANDHİ,Venkatesan SANGAREDDİ,Umapathy MANGALANATHAN,Ravi Marimuthu SHANMUGAM | 605–610 |
| Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study | YÜKSEL ÇAVUŞOĞLU,Şule KORKMAZ,Selda DEMİRTAŞ,Erkan GENCER,Hatice ŞAŞMAZ,FEZAN MUTLU,HAKAN GÜNEŞ,KADİR UĞUR MERT,Sedat ÖZDEMİR,Süleyman KALAYCI,MEHMET BİRHAN YILMAZ | 611–617 |
| Role of ischemia-modified albumin in patients with acute decompensated heart failure (Editorial Comment) | Defeng PAN,Dongye Lİ | 618–619 |
| Which oracle to use for tracking a desynchronized heart? A matter of predictability in contemporary medicine ( Editorial Comment ) | Michele Mario CİULLA | 626–627 |
| Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease | Dursun Çayan AKKOYUN,AYDIN AKYÜZ,ŞEREF ALPSOY,Ahmet GÜREL,NİYAZİ GÜLER,Hasan DEĞİRMENCİ,Ümit GÜRKAN | 628–633 |
| Relationship between red cell distribution width and long-term mortality in patients with non-ST elevation acute coronary syndrome | Adem BEKLER,ERHAN TENEKECİOĞLU,Gökhan ERBAĞ,Ahmet TEMİZ,Burak ALTUN,AHMET BARUTÇU,EMİNE GAZİ,Fahri GÜNEŞ,MUSTAFA YILMAZ | 634–639 |
| The association between platelet/lymphocyte ratio and coronary artery disease severity | Murat YÜKSEL,Abdulkadir YILDIZ,MUSTAFA OYLUMLU,Abdurrahman AKYÜZ,Mesut AYDIN,Hasan KAYA,HALİT ACET,NİHAT POLAT,MEHMET ZİHNİ BİLİK,Sait ALAN | 640–647 |
| Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio |